NICE International, London, UK.
World Bank, Accra, Ghana.
Lancet Oncol. 2014 Mar;15(3):e119-31. doi: 10.1016/S1470-2045(13)70547-3. Epub 2014 Feb 14.
Evidence-informed frameworks for cost-effective cancer prevention and management are essential for delivering equitable outcomes and tackling the growing burden of cancer in all resource settings. Evidence can help address the demand side pressures (ie, pressures exerted by people who need care) faced by economies with high, middle, and low incomes, particularly in the context of transitioning towards (or sustaining) universal health-care coverage. Strong systems, as opposed to technology-based solutions, can drive the development and implementation of evidence-informed frameworks for prevention and management of cancer in an equitable and affordable way. For this to succeed, different stakeholders-including national governments, global donors, the commercial sector, and service delivery institutions-must work together to address the growing burden of cancer across economies of low, middle, and high income.
为了在所有资源环境中提供公平的癌症预防和管理结果，并应对癌症负担不断增加的问题，制定具有成本效益的癌症预防和管理循证框架至关重要。证据可以帮助高、中、低收入经济体应对需求方的压力（即需要医疗服务的人群施加的压力），尤其是在向（或维持）全民医保覆盖过渡的情况下。强大的系统而非基于技术的解决方案，可以推动以公平和负担得起的方式制定癌症预防和管理循证框架。要想取得成功，包括国家政府、全球捐助者、商业部门和服务提供机构在内的不同利益攸关方必须共同努力，应对不同收入水平经济体中癌症负担不断增加的问题。
